33.44 - 34.57
31.40 - 61.90
7.61M / 5.87M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
15.54%
Revenue growth at 50-75% of S's 25.20%. Martin Whitman would worry about competitiveness or product relevance.
13.47%
Gross profit growth at 50-75% of S's 19.20%. Martin Whitman would question if cost structure or brand is lagging.
-9.37%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-9.37%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-6.24%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-6.25%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-6.25%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.58%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-11.88%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-100.00%
Inventory is declining while S stands at 6.12%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-100.00%
Negative asset growth while S invests at 19.10%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
100.00%
BV/share growth above 1.5x S's 34.90%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-100.00%
We’re deleveraging while S stands at 9.72%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
16.60%
R&D dropping or stable vs. S's 37.87%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
10.50%
SG&A declining or stable vs. S's 60.81%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.